Control of HIV during a structured treatment interruption in chronically infected individuals with vigorous T cell responses
Franco Lori(Research Institute for Genetic and Human Therapy), Julianna Lisziewicz(National Institutes of Health), Andrea Foli(University of Pavia), Elisabetta Ravot(Istituti di Ricovero e Cura a Carattere Scientifico), Elena Seminari(Policlinico San Matteo Fondazione), Renato Maserati(Istituti di Ricovero e Cura a Carattere Scientifico), Lucia Whitman(Istituti di Ricovero e Cura a Carattere Scientifico), Lucia Lopalco(Vita-Salute San Raffaele University), F Alberici(Policlinico San Matteo Fondazione), Jianqing Xu(Weifang Medical University)
Cited by 33
Related Papers
Control of HIV despite the Discontinuation of Antiretroviral Therapy
|New England Journal of Medicine|1999|328
Early hypercytokinemia is associated with interferon-induced transmembrane protein-3 dysfunction and predictive of fatal H7N9 infection
|Proceedings of the National Academy of Sciences|2013|287
Immunization with HIV-1 gp41 Subunit Virosomes Induces Mucosal Antibodies Protecting Nonhuman Primates against Vaginal SHIV Challenges
|Immunity|2011|285
Recovery from severe H7N9 disease is associated with diverse response mechanisms dominated by CD8+ T cells
|Nature Communications|2015|276